Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma

  • Authors:
    • Yoshiaki Takahashi
    • Tsuyoshi Noguchi
    • Shinsuke Takeno
    • Yasuhiko Kimura
    • Masahiko Okubo
    • Katsunobu Kawahara
  • View Affiliations

  • Published online on: February 1, 2006     https://doi.org/10.3892/or.15.2.323
  • Pages: 323-328
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The p63 gene is a member of the p53 family that plays a role in cell differentiation, development and carcinogenesis. The relationship between p63 expression and the prognosis of esophageal squamous cell carcinoma (ESCC) remains unknown. The present study examines the clinical impact of p63 in patients with ESCC. Resected specimens from 180 patients with ESCC were immunostained for p63 and p53. After establishing a cut-off value for p63 expression, we statistically examined its clinical impact and relationship to p53 expression. At a 50% cut-off value for p63 expression, the 5-year overall survival was significantly longer in p63-positive (46.4%) than -negative patients (11.1%, p=0.05). Among the 180 ESCC patients, 171 (95.0%) were p63 immunoreactive and only 9 (5.0%) were negative. The correlation between p63 status and clinicopathological parameters was not significant, although p63-negativity tended to correlate with distant metastasis (p=0.06) and clinical stage (p=0.08). Univariate analysis demonstrated significant correlations between patient survival and tumor diameter, depth of invasion, lymphatic invasion, vascular invasion, lymph node metastasis and distant metastasis. The survival of patients who did not express p63 and p53 was obviously unfavorable (p=0.03). Multivariate analysis revealed that only lymph node metastasis was a critical independent prognostic marker for overall survival (p=0.0015). Expression of p63 was not an independent prognostic factor for overall survival in this study (p=0.69). These data suggest that, although a reduced expression of p63 is infrequent, it has a prognostic impact upon patients with ESCC.

Related Articles

Journal Cover

February 2006
Volume 15 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Takahashi Y, Noguchi T, Takeno S, Kimura Y, Okubo M and Kawahara K: Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Oncol Rep 15: 323-328, 2006.
APA
Takahashi, Y., Noguchi, T., Takeno, S., Kimura, Y., Okubo, M., & Kawahara, K. (2006). Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Oncology Reports, 15, 323-328. https://doi.org/10.3892/or.15.2.323
MLA
Takahashi, Y., Noguchi, T., Takeno, S., Kimura, Y., Okubo, M., Kawahara, K."Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma". Oncology Reports 15.2 (2006): 323-328.
Chicago
Takahashi, Y., Noguchi, T., Takeno, S., Kimura, Y., Okubo, M., Kawahara, K."Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma". Oncology Reports 15, no. 2 (2006): 323-328. https://doi.org/10.3892/or.15.2.323